Australia markets closed

ABBV Jan 2025 165.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
28.510.00 (0.00%)
As of 01:47PM EST. Market open.
Full screen
Previous close28.51
Expiry date2025-01-17
Day's range28.51 - 28.51
Contract rangeN/A
Open interest190
  • Yahoo Finance Video

    FTC warns pharma companies on excessive drug patenting

    The Federal Trade Commission (FTC) issued warning letters to several pharmaceutical companies, including AbbVie (ABBV) AstraZeneca (AZN), and Teva (TEVA), over excessive patenting of medications as Medicare negotiates drug costs with the pharma industry. Yahoo Finance Health Reporter Anjalee Khemlani explains the Biden administration's ideas to license patents to lower drug costs for patients. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

  • Zacks

    Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod

    AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.

  • Motley Fool

    3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows

    Buying these shares can provide you with some excellent recurring income while also diversifying your portfolio.